|
|
| Quarterly Results |
|
| Shilpa Medicare Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Omprakash Inani | | Home : Indian Private | Book Value: 269.1395037 | | BSE Code : 530549 | Market Cap: 5100.77 | | NSE Code : SHILPAMED | P / E : 0 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 63.98 | 74.61 | 83.74 | 66.50 | | Other Income | 22.33 | 22.76 | 20.78 | 20.33 | | Total Income | 86.31 | 97.38 | 104.52 | 86.83 | | Total Expenditure | 67.40 | 67.54 | 74.74 | 95.23 | | Operating Profit | 18.91 | 29.84 | 29.78 | -8.40 | | Interest | 2.61 | 5.18 | 6.76 | 6.61 | | Gross Profit | 16.30 | 24.66 | 23.02 | -15.01 | | Depreciation | 12.39 | 12.67 | 12.26 | 11.98 | | Tax | 1.29 | 5.93 | 1.88 | -1.06 | | Deferred Tax | -0.08 | -0.54 | 0.98 | 3.00 | | Reported Profit After Tax | 2.70 | 6.60 | 7.90 | -28.93 |
|
|
|
|
|